This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Molson Coors (TAP) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Molson Coors (TAP) stock is a good choice for value-oriented investors right now from multiple angles.
Should Value Investors Pick Molson Coors (TAP) Stock?
by Zacks Equity Research
Is Molson Coors (TAP) a great pick from the value investor's perspective right now? Read on to know more.
Does AB InBev (BUD) Stock Have Potential to Rebound in 2019?
by Zacks Equity Research
AB InBev (BUD) suffers on account of softness in the beer industry, particularly in the United States, which is hurting its sales. However, its recent venture in cannabis space is encouraging.
Molson Coors (TAP) Shows Resilience: Stock to Surge in 2019?
by Zacks Equity Research
Molson Coors (TAP) displays momentum backed by focus on cost savings and premiumization of its portfolio, which has boosted its top and bottom lines.
AB InBev (BUD) Enters Booming Cannabis Realm With Tilray Deal
by Zacks Equity Research
AB InBev (BUD) announces partnership with the leading marijuana producer, Tilray.
Molson Coors (TAP) Down 2.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Molson Coors (TAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Coca-Cola (KO) Chalks Out Plan for Coffee Business, Cannabis
by Zacks Equity Research
Coca-Cola (KO) reveals strategy for the newly acquired coffee chain Costa, and also puts forward plans for growth in the cannabis space.
Boston Beer (SAM) Outpaces Peers: Surges 81.7% in a Year
by Zacks Equity Research
Boston Beer (SAM) moves ahead of peers based on the progress of its three-point growth plan, focused on cost savings, long-term innovation, and revival of Samuel Adams and Angry Orchard brands.
Molson Coors (TAP) Q3 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Molson Coors (TAP) beats earnings and sales estimates in third-quarter 2018, backed by First Choice strategy, strong brand portfolio, and improved growth in Europe and International business unit.
Molson Coors Brewing (TAP) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Molson Coors (TAP) delivered earnings and revenue surprises of 17.20% and 1.36%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Coca-Cola (KO) Tops Q3 Earnings & Revenues, Retains View
by Zacks Equity Research
Solid growth strategies and productivity efforts aid Coca-Cola's (KO) earnings and sales in third-quarter 2018.
Factors Likely to Influence Molson Coors' (TAP) Q3 Earnings
by Zacks Equity Research
Molson Coors (TAP) has a dismal top and bottom line trend. Also, it continues to battle input cost inflation. However, its restructuring plans to reduce costs and boost profitability are impressive.
Molson Coors Brewing (TAP) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Molson Coors (TAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walmart's Canada Unit Eyes Prospects in Cannabis Products
by Zacks Equity Research
Walmart (WMT) explores opportunities to sell cannabis-infused products in Canada.
Bear of the Day: Constellation Brands (STZ)
by Benjamin Rains
This alcoholic beverage giant is embarking on a new journey and its earnings revisions are trending in the wrong direction.
Molson Coors and HEXO Joint Venture Goes Live as "Truss"
by Zacks Equity Research
Molson Coors Canada (TAP) and Hydropothecary launch its JV, Truss, to explore the non-alcoholic cannabis-infused drinks market, just before cannabis trade is legalized in Canada.
After Coke, It's PepsiCo's Turn to Monitor Cannabis Market
by Zacks Equity Research
The cannabis-infused beverages industry is growing fast, attracting the attention of food and beverage giants.
TAP vs. DVDCY: Which Stock Is the Better Value Option?
by Zacks Equity Research
TAP vs. DVDCY: Which Stock Is the Better Value Option?
Can Molson Coors Survive on Strategies as Beer Loses Fizz?
by Zacks Equity Research
Molson Coors (TAP) looks attractive, based on its focus on cost savings and premiumization as well as exposure to the marijuana space. But, overall softness in the beer industry weighs on the stock.
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
SAM Vs. TAP: Which Stock is Better Placed as Beer Loses Fizz?
by Zacks Equity Research
Beer space suffers due to soft beer sales, thanks to consumers shift to healthier options. However, players with diversified portfolio stand to gain. Let's see which a better stock in this space is.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.
Coke Eyes Cannabis-Infused Beverages, Will Others Follow?
by Zacks Equity Research
Infused-drinks could emerge as the next big thing in the beverage market, attracting the focus of many big players.
Is Coca-Cola's Cannabis Venture a Solution to Its Problems?
by Zacks Equity Research
Coca-Cola (KO) explores the cannabis-infused drinks market to combat the fading popularity of sugary carbonated sodas.
Molson Coors (TAP) Down 2.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Molson Coors (TAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.